Back to Search
Start Over
Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy.
- Source :
-
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2018 May 15; Vol. 32 (5), pp. 223-6. - Publication Year :
- 2018
- Subjects :
- Abiraterone Acetate adverse effects
Antineoplastic Agents adverse effects
Clinical Decision-Making
Docetaxel
Humans
Male
Neoplasm Metastasis
Patient Selection
Prostatic Neoplasms mortality
Prostatic Neoplasms pathology
Risk Factors
Steroid Synthesis Inhibitors adverse effects
Taxoids adverse effects
Time Factors
Treatment Outcome
Abiraterone Acetate therapeutic use
Antineoplastic Agents therapeutic use
Prostatic Neoplasms drug therapy
Steroid Synthesis Inhibitors therapeutic use
Taxoids therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0890-9091
- Volume :
- 32
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Oncology (Williston Park, N.Y.)
- Publication Type :
- Academic Journal
- Accession number :
- 29847851